NeueHealth (NeueHealth) Days Sales Outstanding : 11.18 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NeueHealth Days Sales Outstanding?

NeueHealth's average Accounts Receivable for the three months ended in Dec. 2023 was $36 Mil. NeueHealth's Revenue for the three months ended in Dec. 2023 was $293 Mil. Hence, NeueHealth's Days Sales Outstanding for the three months ended in Dec. 2023 was 11.18.

The historical rank and industry rank for NeueHealth's Days Sales Outstanding or its related term are showing as below:

NEUE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.02 Med: 19.23 Max: 28.78
Current: 11.03

During the past 6 years, NeueHealth's highest Days Sales Outstanding was 28.78. The lowest was 1.02. And the median was 19.23.

NEUE's Days Sales Outstanding is ranked better than
81.25% of 16 companies
in the Healthcare Plans industry
Industry Median: 32.08 vs NEUE: 11.03

NeueHealth's Days Sales Outstanding declined from Dec. 2022 (28.07) to Dec. 2023 (11.18).

NeueHealth Days Sales Outstanding Historical Data

The historical data trend for NeueHealth's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeueHealth Days Sales Outstanding Chart

NeueHealth Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

1.02

21.73

19.23

28.78

9.22

NeueHealth Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial													28.07	8.74	23.41	10.21	11.18

Competitive Comparison of NeueHealth's Days Sales Outstanding

For the Healthcare Plans subindustry, NeueHealth's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeueHealth's Days Sales Outstanding Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NeueHealth's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NeueHealth's Days Sales Outstanding falls into.

NeueHealth Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NeueHealth's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (19.576	+	39.084)	/	2 )	/	1160.802	*	365
=	29.33					/	1160.802	*	365
=	9.22

NeueHealth's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (32.663	+	39.084)	/	2 )	/	292.871	*	365 / 4
=	35.8735					/	292.871	*	365 / 4
=	11.18

NeueHealth (NYSE:NEUE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NeueHealth Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NeueHealth's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NeueHealth (NeueHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NeueHealth Inc (NYSE:NEUE) » Definitions » Days Sales Outstanding

Comparable Companies

PFHO MRAI UNH ELV CI CVS HUM CNC MOH SZSE:000503 ALHC BSP:ODPV3 OSCR CLOV BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

N/A

Address

8000 Norman Center Drive, Suite 900, Minneapolis, MN, USA, 55437

Website

https://www.brighthealthgroup.com

Bright Health Group Inc is a technology-enabled, value-driven healthcare company focused on delivering affordable healthcare to the fast-growing aging and underserved populations in Florida, Texas, and California. It consists of two reportable segments: Bright HealthCare includes delegated senior managed care business that partners with a tight group of aligned providers in California focused on serving aging and underserved populations with unmet clinical needs through a Fully-Aligned Care Model, and Consumer Care includes a value-driven care delivery business that manages risk in partnership with external payors, It aims to significantly reduce the friction and current lack of coordination between payors by delivering on its Fully-Aligned Care Model with multiple payors.

Executives

Mikan George Lawrence Iii	director, officer: CEO and President	200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301
Jay Matushak	officer: Chief Financial Officer	C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437
Jeffrey S Cook	officer: CEO, NeueHealth	C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Jeffrey J Scherman	officer: Chief Accounting Officer	C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437
Cathy R Smith	officer: CFO & CAO	TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403
Jeff Michael Craig	officer: GC & CORPORATE SECRETARY	C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Manuel Kadre	director	2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134
Jeffrey R Immelt	director	GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Nea 18 Vge Gp, Llc	10 percent owner	C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 18 Vge, L.p.	10 percent owner	C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 18 Venture Growth Equity, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 17 Gp, Llc	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 17, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
New Enterprise Associates 17, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Michael A Carson	officer: CEO, Bright HealthCare	C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437